Enpp-1-IN-14
|
化合物ENPP-1-IN-14
|
2687222-59-7
|
GW5074
|
GW5074
|
220904-83-6
|
Dynasore
|
DYNASORE
|
304448-55-3
|
Tie2 kinase inhibitor 1
|
Tie2 kinase inhibitor
|
948557-43-5
|
N-(Pyridin-3-yl)-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzyl)piperidine-1-carboxamide
|
PF 3845
|
1196109-52-0
|
4-(4-(Benzyloxy)benzyl)piperidine hydrochloride
|
4-(4-(苄氧基)苄基)哌啶盐酸盐
|
1177093-20-7
|
BMS-687453
|
BMS 687453
|
1000998-59-3
|
LY2090314
|
LY 2090314
|
603288-22-8
|
AL 082D06
|
AL 082D06游离态
|
256925-03-8
|
BBI-608
|
1134099-70-9
|
1134099-70-9
|
FIIN-2
|
FIIN-2
|
1633044-56-0
|
PDGFR Tyrosine Kinase Inhibitor III
|
PDGFR酪氨酸激酶抑制剂III
|
205254-94-0
|
MMRi62
|
7-((2,3-二氯苯基)(吡啶-2-基氨基)甲基)喹啉-8-醇
|
352693-80-2
|
CU-242
|
16082-64-7
|
16082-64-7
|
Adezmapimod
|
4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑
|
152121-47-6
|
W-9 hydrochloride
|
N-(6-氨基己基)-5-氯-2-萘磺酰胺 盐酸盐
|
69762-85-2
|
MRGPRX1 agonist 1
|
MRGPRX1 agonist 1
|
2377379-39-8
|
N-(2-[P-BROMOCINNAMYLAMINO]ETHYL)-5-ISOQUINOLINESULFONAMIDE HYDROCHLORIDE
|
N-[2-[P-溴苯丙烯盐基氨基]乙基]-5-异喹啉磺酰胺
|
127243-85-0
|
HIF-1 inhibitor-4
|
WAY-299838
|
333357-56-5
|
CP-289503
|
化合物CP-289
|
1349637-14-4
|
GR 125,743
|
化合物GR 125743
|
148547-33-5
|
PF-4708671
|
PF-4708671
|
1255517-76-0
|
CH-223191
|
1-甲基-N-[2-METHYL-4-[2-(2-甲苯基)二氮烯基]苯基-1H-吡唑-5-甲酰胺
|
301326-22-7
|
REMODELIN.HBR
|
REMODELIN
|
1622921-15-6
|
RGX-104(HCl)
|
RGX-104 HCl
|
610318-03-1
|
4'-CHLORO-3-METHOXYCINNAMANILIDE
|
3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺
|
472981-92-3
|
IC 261
|
3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮
|
186611-52-9
|
CK1-IN-1
|
CK1-IN-1
|
1784751-20-7
|
LMPTP INHIBITOR 1 dihydrochloride
|
LMPTP INHIBITOR 1 dihydrochloride
|
2310135-46-5
|
ALW-II-49-7
|
化合物 ALW-II-49-7
|
1135219-23-6
|
GF109203X.HCl
|
3-[1-[3-(二甲基氨基)丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮单盐酸盐
|
176504-36-2
|
BMS-309403
|
BMS309403
|
300657-03-8
|
SB525334
|
6-[2-(1,1-二甲基乙基)-5-(6-甲基-2-吡啶基)-1H-咪唑-4-基]喹喔啉
|
356559-20-1
|
N-(3-(7-(1,3-dimethyl-1H-pyrazol-5-ylamino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-3-(trifluoromethyl)benzamide
|
PLURIPOTIN
|
839707-37-8
|
Mardepodect (PF-2545920)
|
2-[[4-[1-(甲基-11C)-4-(4-吡啶基)-1H-吡唑-3-基]苯氧基]甲基]喹啉
|
1292799-56-4
|
AMG487
|
AMG 487
|
473719-41-4
|
G007-LK
|
G007-LK
|
1380672-07-0
|
6-quinolinyl(3,4,5-trimethoxyphenyl)methanone
|
B014
|
1215208-59-5
|
TM 5275
|
CS-2524
|
1103926-82-4
|
CAIX Inhibitor S4
|
CAIX Inhibitor S4
|
1330061-67-0
|
p38α inhibitor 3
|
WAY-313218
|
260428-69-1
|
JNJ-18038683
|
化合物JNJ-18038683
|
851376-05-1
|
Enpp-1-IN-1
|
Enpp-1-IN-1
|
2289728-58-9
|
ROCK inhibitor-2
|
ROCK inhibitor-2
|
1127308-52-4
|
H7.2HCL
|
H-7双盐酸盐
|
108930-17-2
|
BRD4 Inhibitor-20
|
化合物 BRD4 INHIBITOR-20
|
2490311-14-1
|
Radiprodil
|
RADIPRODIL
|
496054-87-6
|
AZ304
|
AZ304
|
942507-42-8
|
MLN120B.2 HCl
|
MLN120B DIHYDROCHLORIDE
|
1782573-78-7
|
Pizuglanstat
|
化合物PIZUGLANSTAT
|
1244967-98-3
|
N-(2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-2-(4-METHYL-BENZYL)-SUCCINAMIC ACID
|
N-(2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-2-(4-METHYL-BENZYL)-SUCCINAMIC ACID
|
332849-40-8
|
Finasteride Carboxaldehyde
|
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-二甲基-2-氧代乙基)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-十四氢-4a,6a-二甲基-2-氧代-1H-茚并[5,4-f]喹啉-7-羧酰胺
|
154387-61-8
|
KN92 phosphate
|
KN-92 磷酸盐
|
1135280-28-2
|
BIBF-0775
|
BIBF0775
|
334951-90-5
|
LY2584702 Tosylate
|
LY2584702 TOSYLATE
|
1082949-68-5
|
piperidin-1-yl(1-m-tolyl-1H-indazol-6-yl)methanone
|
piperidin-1-yl(1-m-tolyl-1H-indazol-6-yl)methanone
|
451496-96-1
|
MLS1547
|
5-CHLORO-7-[[4-(2-PYRIDINYL)-1-PIPERAZINYL]METHYL]-8-QUINOLINOL
|
315698-36-3
|
BI-7273
|
CS-2327
|
1883429-21-7
|
TUG-469
|
TUG-469
|
1236109-67-3
|
BI 882370
|
BI 882370
|
1392429-79-6
|
UAMC-3203
|
UAMC-3203
|
2271358-64-4
|
Aumitin
|
AUMITIN
|
946293-78-3
|
SERALUTINIB
|
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-
|
1619931-27-9
|
Nampt activator-1
|
化合物 NAMPT ACTIVATOR-1
|
701929-65-9
|
ICG-001
|
ICG-001
|
847591-62-2
|
FG 2216
|
BIQ
|
223387-75-5
|
2-(2-Chlorophenyl)-4-(3-(diMethylaMino)phenyl)-5-Methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
|
2-(2-氯苯基)-4-[3-(二甲基氨基)苯基]-5-甲基-1H-吡唑并[4,3-C]吡啶-3,6(2H,5H)-二酮
|
1218942-37-0
|
TAK-063
|
1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮
|
1238697-26-1
|
LRE1
|
化合物 T15787
|
1252362-53-0
|
4-(4-(Benzyloxy)benzyl)piperidine hydrochloride
|
Pyrrolo[1,2-a]quinoxalin-4(5H)-one,5-[3-[4-(4-chlorophenyl)-1-piperidinyl]propyl]-
|
1380392-05-1
|
SPHINX31
|
CS-2837
|
1818389-84-2
|
Quipazine dimaleate
|
美托拉宗
|
150323-78-7
|
UAMC3203.HCL
|
UAMC-3203 HYDROCHLORIDE
|
2271358-65-5
|
Vodobatinib
|
K0706
|
1388803-90-4
|
H7
|
1-(5-异喹啉磺酰基)-2-甲基哌嗪
|
84477-87-2
|
TT01001
|
1-Piperidinecarboxylic acid, 4-[[[(3,5-dichlorophenyl)amino]thioxomethyl]amino]-, ethyl ester
|
1022367-69-6
|
Menin-MLL inhibitor 20
|
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
|
2448173-47-3
|
DC-TEADin02
|
化合物DC-TEADIN02
|
2380228-45-3
|
CP-447697
|
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺
|
1092847-21-6
|
NLRP3-IN-10
|
化合物 NLRP3-IN-10
|
2641826-39-1
|
Todralazine hydrochloride
|
盐酸托屈嗪
|
3778-76-5
|
hMAO-B-IN-4
|
化合物HMAO-B-IN-4
|
1666119-75-0
|
ROCK-IN-5
|
2-(2-氯-6-氟苯基)-N-(4-(吡啶-4-基)噻唑-2-基)乙酰胺
|
692870-25-0
|
PD169316
|
4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶
|
152121-53-4
|
SKF96365HCl
|
1-[2-(4-甲氧基)-2-[3-(4-甲氧基苯基)丙氧基]乙基]咪唑
|
130495-35-1
|
AT7519
|
4-[(2,6-二氯苄基)氨基]-N-4-哌啶1H-吡唑-3-羧胺
|
844442-38-2
|
1-(4-Methoxyphenyl)-2-methyl-3-nitro-1H-indol-6-ol
|
1-(4-甲氧基苯基)-2-甲基-3-硝基-1H-吲哚-6-醇
|
147591-46-6
|
IWR-1
|
IWR-1
|
1127442-82-3
|
F-15599
|
635323-95-4
|
635323-95-4
|
PS210
|
PS 210
|
1221962-86-2
|
SAPA-1j
|
SMS1-IN-1
|
1807943-38-9
|
CCR8 antagonist 1
|
化合物CCR8 ANTAGONIST 1
|
723304-76-5
|
Merafloxacin
|
CI 934
|
91188-00-0
|
Moracin C
|
5-(6-羟基-2-苯并呋喃基)-2-(3-甲基-2-丁烯基)-1,3-苯二醇
|
69120-06-5
|
N6022
|
N6022
|
1208315-24-5
|
RO3280
|
RO3280
|
1062243-51-9
|
MS402
|
MS-402
|
1672684-68-2
|
C7280948
|
C7280948
|
587850-67-7
|
Ro 31-8220 mesylate
|
RO-31-8220
|
138489-18-6
|
TYRPHOSTIN AG 528
|
酪氨酸磷酸化抑制剂AG528
|
133550-49-9
|